The PTDSS1 gene gives cells instructions to make phosphatidylserine, a fatty substance that helps build cell membranes and supports cell signaling. This gene helps your body keep bones, skin, and many other tissues working in balance. When PTDSS1 activity is changed by a rare disease causing variant, cells can make too much of this membrane fat, which is linked to a condition affecting bone growth, facial features, skin, and learning. PTDSS1 is mainly discussed in rare disease genetics rather than popular culture.

What is a gene?

Genes are stretches of DNA that carry instructions your cells use to make molecules or direct activities in the body. Some genes hold the code for proteins, which are the working parts of cells. Others mainly help regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.

Overview

PTDSS1

Gene function

What if the gene works

The PTDSS1 gene helps your cells make phosphatidylserine, a fat that forms cell membranes. This supports membrane structure and cell signaling.

Risk

What if the gene does not work

Certain variants in the PTDSS1 gene can cause Lenz-Majewski syndrome, marked by unusual bone thickening with short stature, developmental delay, and distinctive facial features. Milder and more severe variants may affect how early features appear and how marked they are.

Treatment

What does that mean for your treatment

For the PTDSS1 gene, no gene-specific treatment or drug choice is currently established in clinical guidelines. Care is guided by a person’s symptoms rather than by a PTDSS1 variant itself, and the PTDSS1 gene is mainly being studied in cell membrane lipid pathways rather than used as a routine treatment target.

Conditions associated with PTDSS1

Lenz-majewski hyperostotic dwarfism

Gene function

What if the gene works

Inside your cells, the PTDSS1 gene helps make an important membrane fat called phosphatidylserine. This substance becomes part of the thin membranes that surround cells and their inner compartments. Understanding how the PTDSS1 gene works helps explain how cells build stable membranes and organize everyday signaling.

Phosphatidylserine making

The PTDSS1 gene helps cells make phosphatidylserine, a key fat that becomes part of cell membranes. It mainly works in the endoplasmic reticulum (a cell network involved in making and managing membranes).

Membrane balance

Phosphatidylserine helps membranes keep the right inner surface and overall structure. This supports stable cell boundaries and the membranes around compartments inside the cell.

Protein docking

Phosphatidylserine gives many proteins a suitable place to attach at the membrane. This helps routine cell signaling stay organized so cells can respond to everyday demands.

What is a variant?

A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many do not produce any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Most disease-causing variants in the PTDSS1 gene make the enzyme too active rather than weaker. These PTDSS1 gene variants often disrupt feedback inhibition, the cell's built in brake, so the enzyme keeps making excess phosphatidylserine, a membrane fat, even when enough is already present. Different variants can increase activity by different amounts, and stronger gain-of-function changes may be linked to earlier onset and more marked features of Lenz-Majewski syndrome.

How variants are linked to conditions

Pathogenic variants in the PTDSS1 gene cause Lenz-Majewski syndrome, a rare condition affecting bone growth and development. This is the main, well-established PTDSS1 gene condition described in human genetics. People with this diagnosis often have short stature, thickened bones, distinctive facial features, and developmental delay or intellectual disability.

A variant is not necessarily a diagnosis

Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a firm diagnosis, especially when several genes and environmental influences are involved. In some situations, though, one well-characterized variant in a particular gene is enough to confirm the diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PTDSS1 gene. For the rare condition linked to harmful PTDSS1 changes, risk is mainly driven by the genetic change itself rather than lifestyle or everyday exposures.

Inheritance of PTDSS1 variants

PTDSS1-related conditions follow an autosomal dominant inheritance pattern. This means a person with a disease-causing variant in one copy of the PTDSS1 gene can pass it on to each child with a 50% chance, which is the key point in how PTDSS1 variants are inherited in families. For the best-known PTDSS1-related condition, many cases happen because of a new (de novo) variant, so the change may appear in a child who did not inherit it from either parent.

What does my PTDSS1 result mean for my family?

For PTDSS1, a disease-causing result is linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change and could consider genetic counseling or testing. If a parent carries it, each child has a 1 in 2 chance of inheriting it. Some PTDSS1 changes happen for the first time in one person, so a parent is not always the source.


Genetic information


Genetic testing

How you find out about variants

PTDSS1 genetic testing looks for DNA changes in the PTDSS1 gene using a blood sample or saliva. A lab reads the gene’s code and compares it with the usual sequence to check for variants that may help explain a person’s features or confirm a suspected diagnosis.

When should I consider getting a genetic test?

PTDSS1 testing may be considered when someone has a rare pattern of very short stature, unusual thickening of the bones, distinctive facial features, and developmental delay that suggest Lenz-Majewski syndrome. A harmful change in PTDSS1 can help confirm this diagnosis and clarify whether other family members are likely to be affected.

A genetic result is only one part of your health story

Genetic test results can offer useful insight, but how much they reveal depends on the specific condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put personal experiences into context.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how your body responds to medicines. Some people break down a medicine faster or slower than expected, while others may be more or less sensitive to its effects. This is a common reason the same treatment can work well for one person but not as well for another, or cause more side effects in some people.

What is Pharmacogenetics?

Pharmacogenetics examines how differences in a person’s genes affect their response to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.


Drugs influenced by the PTDSS1 gene

There are 0 Drugs associated with PTDSS1
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in guiding how medicines work, so any concerns about symptoms, treatment choices, or medication side effects are best discussed with your doctor.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved